Back
Speaker illustration

Doctor Mustafa Yildirim

University Hospital Heidelberg, Heidelberg (Germany)

Presentations

Validation of the 0/3-h algorithm and the APACE criteria to triage patients in the observe-zone

Event: ESC Acute CardioVascular Care 2025

Topic: Non-ST-Elevation Myocardial Infarction (NSTEMI)

Session: Research Prize

Access
Like
Thumbnail

Comparative analysis of dual and single marker strategies for rapid NSTEMI rule-out using cMyBP-C, Copeptin, and hs-cTnT in the emergency department

Event: ESC Acute CardioVascular Care 2025

Topic: Biomarkers

Session: Biomarkers and predictive factors in acute cardiac care

Access
Like
Thumbnail

Identification of patients with suspected NSTE-ACS in the observe zone: evaluating GRACE 1.0 score and a biomarker panel for risk stratification and management optimization

Event: ESC Acute CardioVascular Care 2025

Topic: Biomarkers

Session: Biomarkers and predictive factors in acute cardiac care

Access
Like
Thumbnail

Clinical impact of inappropriate DOAC dosing in atrial fibrillation: insights from a real-world registry

Event: ESC Acute CardioVascular Care 2025

Topic: Epidemiology, Prognosis, Outcome

Session: Arrhythmias in acute cardiac care

Access
Like
Thumbnail

Comparing combined testing of cMyBP-C and hs-cTnT with other algorithms for rapid rule-out of acute myocardial infarction in suspected acute coronary syndrome patients

Event: ESC Congress 2024

Topic: Biomarkers

Session: Troponin and other biomarkers for diagnosis of acute coronary syndromes

Access
Like
Thumbnail

Comparison of the clinical chemistry score to other biomarker algorithms for rapid rule-out of acute myocardial infarction and risk stratification

Event: ESC Congress 2024

Topic: Biomarkers

Session: Troponin and other biomarkers for diagnosis of acute coronary syndromes

Access
Like
Thumbnail

Comparison of the clinical chemistry score to other biomarker algorithms for rapid rule-out of acute myocardial infarction and risk stratification

Event: ESC Acute CardioVascular Care 2024

Topic: Biomarkers

Session: Acute coronary syndromes III: prognosis and complications

Access
Like
Thumbnail

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources